Short course vaginal radiation after hysterectomy
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a short course of targeted vaginal radiation (brachytherapy) after surgery for certain early endometrial cancer. It may help prevent the cancer from coming back in the vaginal area after the uterus has been removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed endometrial cancer (including certain specific types) and your cancer stage/grade matches the trial’s Stage I–II rules
- Your cancer is mostly located in the uterus (not other stages), and it’s recommended that you receive vaginal cuff brachytherapy
- You’ve already had a hysterectomy (uterus removal) and scans/exams show no remaining cancer
- Your health/energy level is good enough to do usual activities (ECOG/WHO performance status 0 to 2)
- You have not had pelvic radiation before, and you don’t have another active cancer needing non-study anti-cancer treatment
- You can sign the consent form and you’re expected to live more than 2 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies giving radiation after surgery for certain early-stage uterine (endometrial) cancer types. It may help lower the chance the cancer comes back, especially for higher-grade cases.
This trial compares different “fractionation” schedules (how often and how many treatments) of vaginal brachytherapy radiation given after surgery for certain early-stage endometrial cancer. It may help find a plan that works well while aiming to control side effects.
This study tests a shorter, more intense course of radiation therapy after surgery for endometrial cancer. It aims to see if it is safe and works as well as standard radiation, while possibly reducing treatment time.
This trial looks at how to guide follow-up (adjuvant) treatment after surgery for certain early-stage, higher-risk endometrial cancer. It may help by tailoring care based on patient and tumor details to lower the chance of the cancer coming back.
This trial tests whether using tumor “molecular” results plus standard risk factors can guide the best type and timing of radiation after surgery for early-stage endometrial cancer. It may help you avoid under- or overtreatment by matching radiotherapy to your specific risk.
This trial tests a shorter, focused radiation treatment to the pelvis after surgery for cervical or uterine cancer. It aims to reduce the chance of cancer coming back in patients whose doctors recommend additional radiation therapy after their surgery.
Hear when a new Endometrial Clear Cell Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.